PRIA Logo™
LouisianaHB 9072026 Regular SessionHouseWALLET

HEALTH CARE/PROVIDERS: Provides civil and criminal immunity for the distribution or use of Naloxone and other opioid antagonists beyond their shelf-life end date

Sponsored By: Dustin Miller (Democratic)

Signed by Governor

Health and Welfare

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

People gain protection for expired naloxone

Louisiana law protects people who prescribe, dispense, distribute, or supply naloxone or other opioid blockers from civil and criminal liability based solely on the medicine’s labeled expiration date having passed. People who supply or give these medicines, including expired doses, during a suspected opioid overdose also receive protection. They must act in good faith and reasonably believe the person is having an opioid-related overdose. This overdose-response protection excludes gross negligence or deliberate or reckless misconduct. Licensed healthcare practitioners are also protected from licensing-board discipline for actions covered by these protections. Federally certified healthcare providers, facilities, and entities must still follow federal rules that prohibit expired drugs.

Sponsors & Cosponsors

Sponsor

  • Dustin Miller

    Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 141 • No: 0

Senate vote • 5/11/2026

Read by title, passed by a vote of 35 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

Yes: 35 • No: 0

House vote • 4/1/2026

Read third time by title, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.

Yes: 96 • No: 0

House vote • 3/25/2026

Reported with amendments

Yes: 10 • No: 0

Actions Timeline

  1. Signed by the Governor. Becomes Act No. 183.

    5/15/2026House

  2. Effective date: 05/15/2026.

    5/15/2026House

  3. Sent to the Governor for executive approval.

    5/13/2026House

  4. Enrolled and signed by the Speaker of the House.

    5/12/2026House

  5. Signed by the President of the Senate.

    5/12/2026Senate

  6. Read by title, passed by a vote of 35 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

    5/11/2026Senate

  7. Received from the Senate without amendments.

    5/11/2026House

  8. Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

    4/28/2026Senate

  9. Read by title and referred to the Legislative Bureau.

    4/27/2026Senate

  10. Reported favorably.

    4/22/2026Senate

  11. Read second time by title and referred to the Committee on Health and Welfare.

    4/7/2026Senate

  12. Read third time by title, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.

    4/1/2026House

  13. Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

    4/1/2026Senate

  14. Scheduled for floor debate on 04/01/2026.

    3/30/2026House

  15. Read by title, amended, ordered engrossed, passed to 3rd reading.

    3/26/2026House

  16. Reported with amendments (10-0).

    3/25/2026House

  17. Read by title, under the rules, referred to the Committee on Health and Welfare.

    3/9/2026House

  18. Prefiled.

    2/27/2026House

  19. Under the rules, provisionally referred to the Committee on Health and Welfare.

    2/27/2026House

  20. First appeared in the Interim Calendar on 2/27/2026.

    2/27/2026House

Bill Text

Related Bills

Back to State Legislation